Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-03-24
1997-05-20
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540557, A61K 3155, C07D49504, C07D24310
Patent
active
056312504
ABSTRACT:
The invention provides lower alcohol solvates of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine (olanzapine) and a process for making such lower alcohol solyates of olanzapine. The invention provides a method for using such solyates of olanzapine to prepare substantially pure anhydrous Form I 2-methyl-thieno-benzodiazepine.
REFERENCES:
patent: 3951981 (1976-04-01), Safir et al.
patent: 4115568 (1978-09-01), Chakrabarti et al.
patent: 4237279 (1980-12-01), Fisher
patent: 4337198 (1982-06-01), Sorg et al.
patent: 4542131 (1985-09-01), Chakrabarti et al.
patent: 5229382 (1993-07-01), Chakrabarti
patent: 5439888 (1995-08-01), Shuman et al.
patent: 5457101 (1995-10-01), Greenwood et al.
patent: 5561127 (1995-10-01), Tehim et al.
Bunnell Charles A.
Hotten Terrence M.
Larsen Samuel D.
Tupper David E.
Boone David E.
Eli Lilly and Company
Lilly Industries Limited
McKane Joseph
Myers, Jr. Richard S.
LandOfFree
Process and solvate of 2-methyl-thieno-benzodiazepine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process and solvate of 2-methyl-thieno-benzodiazepine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process and solvate of 2-methyl-thieno-benzodiazepine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1724032